Medicine and Dentistry
Patient
100%
Age
59%
Duchenne Muscular Dystrophy
43%
Spinal Muscular Atrophy
36%
Infant
32%
Assessment
29%
Child
27%
Upper Limb
25%
Muscle
19%
Therapeutic Procedure
18%
Diseases
18%
Spinal Muscular Atrophy Type 2
17%
Nusinersen
16%
Inpatient
14%
Kugelberg Welander Disease
13%
Magnetic Resonance Imaging
12%
Vision
12%
Phenotype
11%
Diagnosis
11%
Myopathy
11%
Development
10%
Neuromuscular Disease
10%
Gene
9%
Motor Performance
9%
Follow up
9%
Prematurity
9%
Muscular Dystrophy
9%
Deterioration
9%
Werdnig Hoffmann Disease
8%
Exon
8%
Adult
7%
Combination Therapy
7%
Aptitude
7%
Analysis
6%
Brain
6%
Neurologic Examination
6%
Severe Myoclonic Epilepsy of Infancy
6%
Dystrophin
5%
Lesion
5%
Clinical Trial
5%
Pediatrics
5%
Attention
5%
Sleep Disorder
5%
Swallowing
5%
Psychology
Children
28%
Duchenne Muscular Dystrophy
27%
Infant
18%
Spinal Muscular Atrophy
15%
Assessment
15%
Groups
14%
Treatment
11%
Abilities
11%
Tools
6%
Cerebral Palsy
6%
Attention
5%
Biochemistry, Genetics and Molecular Biology
Mutation
21%
Nested Gene
20%
Age
20%
Phenotype
15%
Genetics
12%
SMN2
9%
Development
6%
Time
6%
Spectrum
5%
